Get the Stockscreener App
7.765
5.26%
-0.415
Lifecore Biomedical Inc stock is traded at $7.765, with a volume of 26,848.
It is down -5.26% in the last 24 hours and up +0.39% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$8.18
Open:
$8.14
24h Volume:
26,848
Relative Volume:
0.16
Market Cap:
$291.49M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
155.30
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
-6.63%
1M Performance:
+0.39%
6M Performance:
-3.61%
1Y Performance:
+16.37%
1-Day Range:
$7.745
$8.18
1-Week Range:
$7.745
$8.36
52-Week Range:
$4.76
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.78 | 306.47M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
124.72 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.01 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.80 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
484.14 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, ... - Bluefield Daily Telegraph
Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire
Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR) - Seeking Alpha
Important Notice to Long-Term Shareholders of CarMax, Inc. - GlobeNewswire
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - TMX Newsfile
KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock By Investing.com - Investing.com UK
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - GuruFocus
(LFCR) Volatility Zones as Tactical Triggers - Stock Traders Daily
EBIT per share of Lifecore Biomedical, Inc. – DUS:LDE - TradingView — Track All Markets
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Lifecore Biomedical, Inc.(NasdaqGS: LFCR) added to NASDAQ Biotechnology Index - marketscreener.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc. stock overvalued by current metricsJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - Улправда
Is Lifecore Biomedical Inc. stock positioned for long term growthJuly 2025 Sector Moves & Community Verified Watchlist Alerts - Улправда
How sustainable is Lifecore Biomedical Inc. stock dividend payout2025 Historical Comparison & Fast Moving Trade Plans - Улправда
One Lifecore Biomedical Insider Raised Their Stake In The Previous Year - Yahoo Finance
Can Lifecore Biomedical Inc. stock maintain operating marginsMarket Performance Recap & AI Enhanced Trade Execution Alerts - Улправда
Support Test: Is Lifecore Biomedical Inc. stock vulnerable to regulatory risksWeekly Trend Report & AI Based Buy/Sell Signal Reports - Улправда
Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsEarnings Overview Report & Daily Stock Trend Watchlist - ulpravda.ru
Can Lifecore Biomedical Inc. stock maintain growth trajectoryCEO Change & Real-Time Buy Signal Alerts - DonanımHaber
Is Lifecore Biomedical Inc. stock dividend yield sustainableJuly 2025 Short Interest & Trade Opportunity Analysis Reports - DonanımHaber
Can Lifecore Biomedical Inc. stock resist sector downturnsDollar Strength & Verified High Yield Trade Plans - DonanımHaber
How institutional buying supports Lifecore Biomedical Inc. stockTreasury Yields & AI Forecast for Swing Trade Picks - Bölüm Sonu Canavarı
Investment Report: Is Lifecore Biomedical Inc. stock overvalued by current metricsQuarterly Performance Summary & AI Powered Market Entry Strategies - Улправда
Lifecore Biomedical to Join Nasdaq Biotech Index - marketscreener.com
Lifecore Biomedical to be Added to Nasdaq Biotech Index - The Manila Times
Is Lifecore Biomedical Inc. stock vulnerable to regulatory risksJuly 2025 WrapUp & Consistent Return Investment Signals - Улправда
Lifecore signs CDMO agreement with global pharma company By Investing.com - Investing.com Nigeria
Entry Recap: Why Lifecore Biomedical Inc. stock is favored by top institutionsWeekly Trade Report & Weekly Momentum Picks - moha.gov.vn
Lifecore Biomedical, Inc. Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - marketscreener.com
Lifecore signs CDMO agreement with global pharma company - Investing.com India
Lifecore Biomedical Signs Agreement for Injectable Pharmaceutical Development Services with Major Global Partner - Quiver Quantitative
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect - ACCESS Newswire
Keybanc Initiates Coverage of Lifecore Biomedical (LFCR) with Sector Weight Recommendation - MSN
Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Understanding the Setup: (LFCR) and Scalable Risk - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
What analysts say about Lifecore Biomedical Inc LDE stockFederal Reserve Announcements & Outperform the Market with Aggressive Picks - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc a good long term investmentMarket Sentiment Report & High Yield Stock Picks - earlytimes.in
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulationWeekly Risk Report & Community Consensus Trade Signals - Newser
Will Lifecore Biomedical Inc. (LDE) stock attract long term capital inflowsWall Street Watch & Accurate Entry/Exit Alerts - Newser
The Technical Signals Behind (LFCR) That Institutions Follow - news.stocktradersdaily.com
Will Lifecore Biomedical Inc. (LDE) stock split increase liquidityMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership - Newser
Will Lifecore Biomedical Inc. (LDE) stock keep raising dividendsBreakout Watch & Daily Stock Trend Watchlist - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.42%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):